Silji Abraham - 29 Oct 2024 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP, Chief Technology Officer
Signature
/s/ Louis Lalli
Issuer symbol
WST
Transactions as of
29 Oct 2024
Net transactions value
-$57,388
Form type
4
Filing time
31 Oct 2024, 11:50:15 UTC
Previous filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $0 +458 +16% $0.000000 3,318 29 Oct 2024 Direct
transaction WST Common Stock Tax liability $57,388 -180 -5.4% $318.41 3,138 29 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Rst. Stock Unit Options Exercise $0 -458 -100% $0.000000 0 29 Oct 2024 Common Stock 458 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These units were payable in cash or the company's common stock upon the lapse of restrictions on the transaction date shown.
F2 Release of restricted stock units.